Medicines Value Programme Patient Groups Engagement Event

Medicines Value Programme

Led by Dr Bruce Warner, Deputy Chief Pharmaceutical Officer, NHS England

 Biosimilar medicines

Led by Ailsa Bosworth, Chief Executive, National Rheumatoid Arthritis Society; and Dr Fraser Cummings, Consultant Gastroenterologist, University Hospital Southampton NHS FT

·      Biosimilar medicines are biological medicines which are highly similar to another biological medicine already licensed for use.

·      To be licensed, a biosimilar medicine must be shown to have no clinically meaningful differences from the originator medicine in terms of quality, safety and efficacy.

·      Where NICE has already recommended the originator biological medicine, the same guidance will normally apply to a biosimilar.

Polypharmacy, or the taking of multiple medicines, and deprescribing

Led by Graham Prestwich, Lay Member PPI, NHS Leeds North CCG; Lay Member, Leeds Area Prescribing Committee; Lelly Oboh, Consultant Pharmacist, Care of Older People, Guy’s & St Thomas’ NHS FT and NHS Specialist Pharmacy Services; and Nina Barnett, FRPharmS, FFRPS, Consultant Pharmacist, Care of Older People, London North West Healthcare NHS Trust, and NHS Specialist Pharmacy Services

 The event will begin with coffee/tea and registration, with the first speaker starting at 13.15.

 A detailed agenda will be sent out before the event.

Questions about this event?

Name:

Email:

Telephone: